资讯
1小时内
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
临床结果
融资
3 小时之前
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
上市批准引进/卖出
3 小时之前
并购引进/卖出
3 小时之前
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
临床结果
2026-11-17
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
上市批准临床结果
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
临床结果上市批准孤儿药
2026-11-17
FDA OKs third renal indication for Roche's Gazyva, this time primary membranous nephropathy
临床结果上市批准优先审批突破性疗法
2026-11-17
AstraZeneca's next-gen C5 inhibitor Klygefa approved in US, EU for gMG
临床结果上市批准
2026-11-14
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
申请上市上市批准临床结果